Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISAFE: Safety of Ibuprofen After Major Orthopaedic Surgeries
NCT05575700Phase 4Completed
- Sponsor
- Næstved Hospital
- Start
- Apr 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in postoperative pain comparing Ibuprofen with Placebo (2 arms). Primary endpoint: Composite outcome of serious adverse events at 90 days. Started Apr 2023; status: completed.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05575700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575700.